417.09MMarket Cap-1543P/E (TTM)
3.385High3.145Low2.07MVolume3.370Open3.345Pre Close6.69MTurnover3.23%Turnover RatioLossP/E (Static)131.16MShares9.86052wk High2.20P/B203.95MFloat Cap3.14552wk Low--Dividend TTM64.14MShs Float21.730Historical High--Div YieldTTM7.18%Amplitude3.145Historical Low3.231Avg Price1Lot Size
Prime Medicine Stock Forum
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress
📊⚡️📊
Prime Medicine Inc - to Receive $110 Mln Upfront, Potential for $3.5 Bln in Milestones
No comment yet